These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 1985074)

  • 21. An eosinophilia-myalgia syndrome associated with an L-tryptophan containing product.
    Saag KG; Goldschmidt R; Vernof H; Golbus J
    J Rheumatol; 1990 Nov; 17(11):1551-3. PubMed ID: 2273501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A histopathologic comparison of Shulman's syndrome (diffuse fasciitis with eosinophilia) and the fasciitis associated with the eosinophilia-myalgia syndrome.
    Feldman SR; Silver RM; Maize JC
    J Am Acad Dermatol; 1992 Jan; 26(1):95-100. PubMed ID: 1732344
    [TBL] [Abstract][Full Text] [Related]  

  • 23. L-tryptophan-related eosinophilia-myalgia syndrome: a case report.
    Wong CB; Love J; Pon E; Scottolini AG; Manoukian AA
    Hawaii Med J; 1990 Aug; 49(8):295-8, 303. PubMed ID: 2211094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tryptophan-associated eosinophilic connective-tissue disease. A new clinical entity?
    Clauw DJ; Nashel DJ; Umhau A; Katz P
    JAMA; 1990 Mar; 263(11):1502-6. PubMed ID: 2308182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Eosinophilia-myalgia syndrome and L-tryptophan intake].
    von Gizycki-Nienhaus B; Meurer M; Krieg T; Braun-Falco O
    Hautarzt; 1991 Mar; 42(3):179-82. PubMed ID: 1829070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Eosinophilia-myalgia syndrome. Recognition of a distinct clinicopathologic entity.
    Gibbons RB; Metzger JR
    Arch Intern Med; 1990 Oct; 150(10):2175-7. PubMed ID: 2222104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Eosinophilic fasciitis is clinically distinguishable from the eosinophilia-myalgia syndrome and is not associated with L-tryptophan use.
    Varga J; Griffin R; Newman JH; Jimenez SA
    J Rheumatol; 1991 Feb; 18(2):259-63. PubMed ID: 2023221
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Eosinophilia-myalgia syndrome due to L-tryptophan ingestion. Report of four cases and review of the Maryland experience.
    Roubenoff R; Coté T; Watson R; Levin ML; Hochberg MC
    Arthritis Rheum; 1990 Jul; 33(7):930-8. PubMed ID: 2369429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The eosinophilia-myalgia syndrome with neuritis associated with L-tryptophan use.
    Dicker RM; James N; Cunha BA
    Ann Intern Med; 1990 Jun; 112(12):957-8. PubMed ID: 2339856
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Two cases of L-tryptophan ingestion induced eosinophilia-myalgia syndrome].
    Mizutani T; Mizutani H; Hashimoto K; Kishida M; Taniguchi H; Okada H; Murata M; Nakamura Y; Shimizu M
    Nihon Hifuka Gakkai Zasshi; 1991 Apr; 101(5):561-6. PubMed ID: 1890752
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of the eosinophilia-myalgia syndrome with the ingestion of tryptophan.
    Hertzman PA; Blevins WL; Mayer J; Greenfield B; Ting M; Gleich GJ
    N Engl J Med; 1990 Mar; 322(13):869-73. PubMed ID: 2314421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Eosinophilia-myalgia syndrome].
    Reinauer S; Plewig G
    Hautarzt; 1991 Mar; 42(3):137-9. PubMed ID: 2055761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Eosinophilia-myalgia syndrome after L-tryptophan intake].
    Zillikens D; Bammel A; Lurz C; Elsner P; Burg G
    Hautarzt; 1991 Mar; 42(3):154-7. PubMed ID: 2055764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Environmental pathology. Mast cell and eosinophil infiltration in intestinal mucosa of Lewis rats treated with L-tryptophan implicated in human eosinophilia myalgia syndrome.
    DeSchryver-Kecskemeti K; Gramlich TL; Crofford LJ; Rader JI; Page SW; Needham LL; Hill RH; Sternberg EM
    Mod Pathol; 1991 May; 4(3):354-7. PubMed ID: 2068062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generalized morphea with peripheral eosinophilia, fasciitis and myositis.
    King DF; Dore RK; Gilbert DJ; Gurevitch AW; Hirose FM
    Int J Dermatol; 1980 Apr; 19(3):149-53. PubMed ID: 7190134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Eosinophilia-myalgia syndrome. A clinical case series of 21 patients. New Mexico Eosinophilia-Myalgia Syndrome Study Group.
    Philen RM; Eidson M; Kilbourne EM; Sewell CM; Voorhees R
    Arch Intern Med; 1991 Mar; 151(3):533-7. PubMed ID: 2001136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Absent neutrophil alkaline phosphatase in the eosinophilia myalgia syndrome associated with L-tryptophan use.
    Jaffe JP; Gertner E; Miller W
    Am J Hematol; 1991 Apr; 36(4):280-1. PubMed ID: 2012075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of diffuse fasciitis with eosinophilia during L-tryptophan treatment: demonstration of elevated type I collagen gene expression in affected tissues. A clinicopathologic study of four patients.
    Varga J; Peltonen J; Uitto J; Jimenez S
    Ann Intern Med; 1990 Mar; 112(5):344-51. PubMed ID: 2306063
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Tryptophan-induced fasciitis-scleroderma-eosinophilia syndrome].
    Schnabel A; Reinhold-Keller E; Wolff HH; Gross WL
    Dtsch Med Wochenschr; 1991 Aug; 116(31-32):1180-5. PubMed ID: 1860421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Eosinophilia-myalgia syndrome.
    Kazura JW
    Cleve Clin J Med; 1991; 58(3):267-70. PubMed ID: 1893558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.